BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 16287961)

  • 1. The IDEAL cholesterol: lower is better.
    Cannon CP
    JAMA; 2005 Nov; 294(19):2492-4. PubMed ID: 16287961
    [No Abstract]   [Full Text] [Related]  

  • 2. Torcetrapib and atorvastatin.
    Shear CL
    N Engl J Med; 2005 Oct; 353(14):1527-9; author reply 1527-9. PubMed ID: 16207861
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comment from the cardiologic viewpoint].
    Lüscher TF
    Praxis (Bern 1994); 2009 Feb; 98(3):129-30. PubMed ID: 19180438
    [No Abstract]   [Full Text] [Related]  

  • 4. Statins for patients with type 2 diabetes.
    Auer J; Berent R; Weber T; Eber B
    Lancet; 2004 Nov 27-Dec 3; 364(9449):1933-4. PubMed ID: 15566997
    [No Abstract]   [Full Text] [Related]  

  • 5. No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin.
    Singhal MK; Bhaskaran S; Szabo T; La Rosa R
    Perit Dial Int; 1999; 19(1):89-91. PubMed ID: 10201354
    [No Abstract]   [Full Text] [Related]  

  • 6. Statins for patients with type 2 diabetes.
    Pimpinella G; Bertini Malgarini R; Martini N
    Lancet; 2004 Nov 27-Dec 3; 364(9449):1933; author reply 1933. PubMed ID: 15566999
    [No Abstract]   [Full Text] [Related]  

  • 7. High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.
    Pedersen TR; Faergeman O; Kastelein JJ; Olsson AG; Tikkanen MJ; Holme I; Larsen ML; Bendiksen FS; Lindahl C; Szarek M; Tsai J;
    JAMA; 2005 Nov; 294(19):2437-45. PubMed ID: 16287954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of atorvastatin compared with simvastatin in patients with hypercholesterolemia.
    Farnier M; Portal JJ; Maigret P
    J Cardiovasc Pharmacol Ther; 2000 Jan; 5(1):27-32. PubMed ID: 10687671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the efficacy and safety of atorvastatin and simvastatin in Asians with elevated low-density lipoprotein-cholesterol--a multinational, multicenter, double-blind study.
    Wu CC; Sy R; Tanphaichitr V; Hin AT; Suyono S; Lee YT
    J Formos Med Assoc; 2002 Jul; 101(7):478-87. PubMed ID: 12353340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of simvastatin and atorvastatin up to maximal recommended doses in a large multicenter randomized clinical trial.
    Illingworth DR; Crouse JR; Hunninghake DB; Davidson MH; Escobar ID; Stalenhoef AF; Paragh G; Ma PT; Liu M; Melino MR; O'Grady L; Mercuri M; Mitchel YB;
    Curr Med Res Opin; 2001; 17(1):43-50. PubMed ID: 11464446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increasing HDL Cholesterol Levels.
    Brewer HB
    N Engl J Med; 2004 Apr; 350(15):1491-4. PubMed ID: 15071124
    [No Abstract]   [Full Text] [Related]  

  • 12. A single-centre retrospective observational study to evaluate the change in total cholesterol and LDL cholesterol in hyperlipidaemic patients switched from atorvastatin to simvastatin.
    Raal FJ
    Cardiovasc J S Afr; 2004; 15(3):118-23. PubMed ID: 15258621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hypercholesterolemia in patients with metabolic syndrome: how do different statins compare?
    Knopp RH; Paramsothy P
    Nat Clin Pract Endocrinol Metab; 2006 Mar; 2(3):136-7. PubMed ID: 16932272
    [No Abstract]   [Full Text] [Related]  

  • 14. HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events.
    Barter P; Gotto AM; LaRosa JC; Maroni J; Szarek M; Grundy SM; Kastelein JJ; Bittner V; Fruchart JC;
    N Engl J Med; 2007 Sep; 357(13):1301-10. PubMed ID: 17898099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aggressive low-density lipoprotein cholesterol lowering in secondary prevention of coronary heart disease.
    Clearfield M
    Curr Atheroscler Rep; 2006 Jan; 8(1):7-8. PubMed ID: 16455005
    [No Abstract]   [Full Text] [Related]  

  • 16. The nature of the statins.
    Jones PH
    Circulation; 2000 Feb; 101(8):E89. PubMed ID: 10694539
    [No Abstract]   [Full Text] [Related]  

  • 17. LDL-C/HDL-C ratio in subjects with cardiovascular disease and a low HDL-C: results of the RADAR (Rosuvastatin and Atorvastatin in different Dosages And Reverse cholesterol transport) study.
    Jukema JW; Liem AH; Dunselman PH; van der Sloot JA; Lok DJ; Zwinderman AH
    Curr Med Res Opin; 2005 Nov; 21(11):1865-74. PubMed ID: 16307708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time as a variable with niacin extended-release/lovastatin vs. atorvastatin and simvastatin.
    Bays HE; McGovern ME
    Prev Cardiol; 2005; 8(4):226-33. PubMed ID: 16230877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparative study of atorvastatin and simvastatin as monotherapy for mixed hyperlipidaemia in Type 2 diabetic patients.
    Chan WB; Ko GT; Yeung VT; Osaki R; Ma RC; So WY; Chow CC
    Diabetes Res Clin Pract; 2004 Oct; 66(1):97-9. PubMed ID: 15364167
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of the impact of atorvastatin and simvastatin on apoA-I kinetics in men.
    Mauger JF; Couture P; Paradis ME; Lamarche B
    Atherosclerosis; 2005 Jan; 178(1):157-63. PubMed ID: 15585213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.